Target intelligence / Profile preview

Bacterial 30S ribosomal initiation complex interface (30S IC interface)

Target
30S IC interface
Molecular classification
Ribonucleoprotein complex, Translation initiation machinery, Bacterial ribosome subunit interface
01

Overview

The bacterial 30S ribosomal initiation complex interface is a highly coordinated molecular assembly essential for the start of protein synthesis in bacteria (Gualerzi & Pon, 2015) [1]. It involves the interaction between the 30S small ribosomal subunit, messenger RNA, and three specific initiation factors: IF1, IF2, and IF3. This interface ensures that the initiator transfer RNA (fMet-tRNA) is correctly positioned at the start codon within the ribosomal P-site, a process critical for maintaining the translational reading frame. Because the architecture and regulation of bacterial initiation differ significantly from the eukaryotic process, this interface represents a selective target for antimicrobial agents (Wilson, 2014) [4]. Antibiotics such as kasugamycin and GE81112 exert their effects by binding to this interface, thereby obstructing the binding of initiation factors or the recruitment of the initiator tRNA (Schluenzen et al., 2006; Brandi et al., 2006) [2, 3]. Such interference prevents the subsequent docking of the 50S large ribosomal subunit, effectively halting the formation of the functional 70S ribosome and stopping bacterial growth. Consequently, this target is a focal point for developing new classes of antibiotics to address the rising challenge of multi-drug resistant infections.

Other names
30S initiation complex30S ICBacterial translation initiation complexIF-30S subunit interface
02

Mechanism of action

Inhibition of the assembly of the 30S initiation complex or prevention of its transition to the 70S initiation complex by interfering with initiation factor binding or tRNA positioning.

03

Biological functions

Protein synthesisTranslation initiationStart codon recognitionRibosome assembly
04

Disease associations

Infection
05

Safety considerations

Mitochondrial ribosome cross-reactivityOtotoxicityNephrotoxicityDevelopment of antibiotic resistance
06

Interacting drugs

Kasugamycin

4 more in the full profile.

07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial protein synthesis rateBacterial loadRibosomal profiling

Beyond the preview

Go deeper on Bacterial 30S ribosomal initiation complex interface (30S IC interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 30S ribosomal initiation complex interface (30S IC interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call